| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $441K | -77.1% |
| R&D Expense | $24.4M | +77.3% |
| SG&A Expense | $17.2M | +67.4% |
| Operating Income | -$68.5M | -150.5% |
| Pre-tax Income | -$35.0M | -11.1% |
| Income Tax | $114K | +714.3% |
| Net Income | -$35.1M | -11.4% |
| EPS (Basic) | -$7.94 | +93.0% |
| EPS (Diluted) | -$20.91 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $134.5M | +1714.5% |
| Current Assets | $138.9M | +1554.4% |
| Total Assets | $150.7M | +618.0% |
| Current Liabilities | $7.0M | +50.7% |
| Total Liabilities | $17.7M | +29.3% |
| Stockholders' Equity | $133.0M | +1721.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.1M | -59.9% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $356K | +367.7% |
| Financing Cash Flow | $175.8M | +602.2% |
| Free Cash Flow | -$49.1M | -59.1% |
| +81.7% |